Limes Schlosskliniken AG: Audited consolidated financial statements 2021 / Approval and adoption of the consolidated financial statements per 31.12.2021 of LIMES Schlosskliniken
|
DGAP-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Annual Results/Forecast DGAP-Adhoc: Limes Schlosskliniken AG: Audited consolidated financial statements 2021 / Approval and adoption of the consolidated financial statements per 31.12.2021 of LIMES Schlosskliniken
- Sales Revenue EUR 23.4m; (p. y. EUR 11.0m) + 112.7% - Total Revenue: 25.2 Mio. EUR (p. y. EUR 11.2m) + 125.7 % - Gross earnings (EBITDA) +6,015 kEUR; (p. y. +838 kEUR) - Operating result (EBIT) + 4,530 kEUR; (p. y. -427 kEUR) - Earnings before taxes (EBT) +4,305 kEUR; (Vj. -691 kEUR) - Earnings after minorities and after taxes (EAT) 3,944 kEUR; (Vj. -694 TEUR) - Earnings per share 13.45 kEUR; (Vj. -2.37 kEUR) We assume that we will be able to further increase capacity utilisation at the existing locations in the current 2022 financial year. According to the current state, we are planning to open the new LIMES Schlossklinik "Bergisches Land" in Lindlar near Cologne on 01.09.2022. Due to compensation payments caused by project delays, the planned start-up losses should not occur in the previous form. Our revenue and earnings forecasts for 2022 are in the range of EUR 27m with an operating result (EBITDA) of approximately EUR 8m.
29-Apr-2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1340145 |
| End of Announcement | DGAP News Service |
|
|
1340145 29-Apr-2022 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.